Keeping Current CME podcast

JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

0:00
38:19
Recuar 15 segundos
Avançar 15 segundos

See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes.

Credit available for this activity expires: 12/10/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu

Mais episódios de "Keeping Current CME"